Semble funding news – UK-based Semble Secures $15Million in Series B Round Funding
Oct 30, 2024 | By Kailee Rainse
Semble, a health tech software company that helps providers organize their data, has secured $15 million in Series B funding led by Mercia Ventures, with participation from Octopus Ventures, Smedvig Ventures, and Triple Point.
Funding utilisation
This investment will help it strengthen its position in the UK and expand into France where it recently launched. The funding will enhance its automation and integration features to serve both small and large healthcare providers.
In England, doctors lose 13.5 million working hours each year due to poor IT systems. It was founded by Christoph Lippuner and Mikael Landau, who previously built a successful startup and saw the difficulties in the healthcare industry.
Read also - Oriole Networks funding news – London-based Oriole Networks Secures an Additional €20.2 Million Funding
They started Semble with the goal of reducing the administrative workload on medical professionals, believing that a more connected system would improve patient care.
Semble offering
It’s platform helps healthcare businesses automate tasks and securely share patient data by connecting with other systems like hospitals, labs, and pharmacies.
Christoph Lippuner, CEO, commented: “Amplifying the impact of healthcare professionals is central to our mission. For too long, they have worked with outdated systems that take them away from what matters most – the patient. With this latest funding, we are looking to bring Semble to professionals across the UK and France, empowering them to spend more time on patient care. We will continue to invest heavily in workflow automation and integrations, positioning Semble at the forefront of AI-driven solutions, and ultimately creating a more connected healthcare ecosystem.”
Alex Gwyther of Mercia Ventures added: “The healthcare market is experiencing significant growth, but the industry’s continued reliance on legacy systems poses a real threat to its future. Semble is pioneering an all-in-one clinical system that enables healthcare businesses to automate many aspects of their practice. This investment will help Semble accelerate product development and expand its presence in the UK and France, empowering healthcare organisations to deliver on their digital transformation and transform their patients' experience. With the founders’ first-hand understanding of the challenges in the healthcare sector and its rapid growth to date, we are in no doubt that Semble is well poised to seize this massive market opportunity.”
About Semble
Semble is used by various healthcare providers, from consultants to GPs, to manage their daily operations. Its user-friendly workflows and integrations provide the tools needed to run and grow their practices.